Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea

BACKGROUND: We aimed to investigate the effectiveness and safety of adding basal insulin to initiating dipeptidyl peptidase-4 (DPP-4) inhibitor and metformin and/or sulfonylurea (SU) in achieving the target glycosylated hemoglobin (HbA1c) in patients with type 2 diabetes mellitus (T2DM). METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yu Mi, Jung, Chang Hee, Lee, Seung-Hwan, Kim, Sang-Wook, Song, Kee-Ho, Kim, Sin Gon, Kim, Jae Hyeon, Cho, Young Min, Park, Tae Sun, Ku, Bon Jeong, Koh, Gwanpyo, Kim, Dol Mi, Lee, Byung-Wan, Park, Joong-Yeol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712234/
https://www.ncbi.nlm.nih.gov/pubmed/31237133
http://dx.doi.org/10.4093/dmj.2018.0092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712234/
https://www.ncbi.nlm.nih.gov/pubmed/31237133
http://dx.doi.org/10.4093/dmj.2018.0092

Ejemplares similares